Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5863/1551-6776-20.1.66 http://scihub22266oqcxt.onion/10.5863/1551-6776-20.1.66 C4353203!4353203!25859173     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Pediatr+Pharmacol+Ther 2015 ; 20 (1): 66-9 Nephropedia Template TP {{tp|p=25859173|t=2015. Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to ?2-agonist Treatment |pdf=|usr=}}{{25859173}} gab.com Text Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to 2-agonist Treatment JO: J Pediatr Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=25859173 #FOAvip To present the case of a patient with persistent bronchospasm, refractory to treatment with ?2-agonists, that resolved promptly with continuous inhalation of large dose (1000 mcg/hr) ipratropium bromide, and to discuss the possibility of tolerance to ?2-agonists as the cause for his failure to respond to adrenergic medications. The patient had received multiple doses of albuterol, as well as subcutaneous terbutaline (0.3 mg), intravenous magnesium sulfate (1 g) and intravenous dexamethasone (10 mg) prior to his admission to the intensive care unit. He remained symptomatic despite systemic intravenous steroids, continuous intravenous terbutaline (up to 0.6 mcg/kg/min), and continuous nebulized albuterol (up to 20 mg/hr for 57 hr) followed by 49 hours of continuous levalbuterol (7 mg/hr). Due to the lack of response, all ?2-agonists were discontinued at 106 hours post-admission, and he was started on large dose ipratropium bromide (1000 mcg/hr) by continuous nebulization. Clinical improvement was evident within 1 hour and complete resolution of his symptoms within 4 hours. Continuous inhalation of large dose ipratropium bromide may be an effective regimen for the treatment of patients hospitalized with acute asthma who are deemed to be nonresponsive and/or tolerant to ?2-agonist therapy. Twit Text FOAVip Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to 2-agonist Treatment ????J Pediatr Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=25859173 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25859173 #FOAvip English Wikipedia <ref>{{Cite pmid|25859173}}</ref> Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to ?2-agonist Treatment #MMPMID25859173 Koumbourlis AC; Mastropietro C J Pediatr Pharmacol Ther 2015[Jan]; 20 (1): 66-9 PMID25859173show ga To present the case of a patient with persistent bronchospasm, refractory to treatment with ?2-agonists, that resolved promptly with continuous inhalation of large dose (1000 mcg/hr) ipratropium bromide, and to discuss the possibility of tolerance to ?2-agonists as the cause for his failure to respond to adrenergic medications. The patient had received multiple doses of albuterol, as well as subcutaneous terbutaline (0.3 mg), intravenous magnesium sulfate (1 g) and intravenous dexamethasone (10 mg) prior to his admission to the intensive care unit. He remained symptomatic despite systemic intravenous steroids, continuous intravenous terbutaline (up to 0.6 mcg/kg/min), and continuous nebulized albuterol (up to 20 mg/hr for 57 hr) followed by 49 hours of continuous levalbuterol (7 mg/hr). Due to the lack of response, all ?2-agonists were discontinued at 106 hours post-admission, and he was started on large dose ipratropium bromide (1000 mcg/hr) by continuous nebulization. Clinical improvement was evident within 1 hour and complete resolution of his symptoms within 4 hours. Continuous inhalation of large dose ipratropium bromide may be an effective regimen for the treatment of patients hospitalized with acute asthma who are deemed to be nonresponsive and/or tolerant to ?2-agonist therapy. äContinuous Inhalation of Ipratropium Bromide for Acute Asthma Refracto(epmc).pdf DeepDyve Pubget Overpricing